15894902
|
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. |
J Hypertens |
2005 |
Karas M;Lacourciere Y;LeBlanc AR;Nadeau R;Dube B;Florescu M;Lamarre-Cliche M;Poirier L;Larochelle P;de Champlain J |
View
More |
2843086
|
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. |
Antimicrob Agents Chemother |
1988 |
Wyde PR;Six HR;Wilson SZ;Gilbert BE;Knight V |
View
More |
28576855
|
Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy. |
Physiol Rep |
2017 |
Isobe-Sasaki Y;Fukuda M;Ogiyama Y;Sato R;Miura T;Fuwa D;Mizuno M;Matsuoka T;Shibata H;Ito H;Ono M;Abe-Dohmae S;Kiyono K;Yamamoto Y;Kobori H;Michikawa M;Hayano J;Ohte N |
View
More |
3232968
|
Failure to demonstrate synergy between interferon-alpha and a synthetic antiviral, enviroxime, in rhinovirus infections in volunteers. |
Antiviral Res |
1988 |
Higgins PG;Barrow GI;al-Nakib W;Tyrrell DA;DeLong DC;Lenox-Smith I |
View
More |
4333893
|
Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees. |
Appl Microbiol |
1972 |
Shipkowitz NL;Bower RR;Schleicher JB;Aquino F;Appell RN;Roderick WR |
View
More |
6287928
|
Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. |
Antimicrob Agents Chemother |
1982 |
Hayden FG;Gwaltney JM Jr |
View
More |
6297380
|
Topical enviroxime against rhinovirus infection. |
Antimicrob Agents Chemother |
1982 |
Levandowski RA;Pachucki CT;Rubenis M;Jackson GG |
View
More |